ClinicalTrials.Veeva

Menu

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy (TCM)

P

Peking University Cancer Hospital & Institute

Status and phase

Active, not recruiting
Phase 2

Conditions

Cancer-related Problem/Condition

Treatments

Drug: Placebo
Drug: TCM Formula

Study type

Interventional

Funder types

Other

Identifiers

NCT05229029
SF2020-2-1023 (Other Grant/Funding Number)
CHEM FATI

Details and patient eligibility

About

This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.

Full description

In this study, symptomatic indicators and quality of life were used as the main evaluation indicators. Patients with moderate to severe CRF who received dual drug chemotherapy were given traditional Chinese medicine compound and placebo intervention respectively. The data of fatigue symptoms, quality of life, sleep quality, blood routine test, liver and kidney function were observed and compared, so as to verify the traditional Chinese medicine compound prescription in improving the CRF symptoms and quality of life of chemotherapy patients validity.

Enrollment

196 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Malignant tumor patients with pathological diagnosis
  • Men and women aged 18-75
  • KPS score ≥ 70, expected survival time more than 6 months
  • The function of heart, lung, liver and kidney was normal
  • Hemoglobin ≥ 8g
  • Neuroendocrine function is normal
  • BMI ≥ 18.5.
  • Cancer pain, VAS score < 3
  • Fatigue score ≥ 4
  • syndrome differentiation is deficiency of Qi and blood

Exclusion criteria

  • Brain metastases with Symptomatic
  • Mental disease
  • Severe infection
  • Insomniacs
  • Pregnant or lactating women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

196 participants in 2 patient groups, including a placebo group

TCM decoction
Experimental group
Description:
Compound granules of Traditional Chinese Medicine
Treatment:
Drug: TCM Formula
placebo
Placebo Comparator group
Description:
Placebo only
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Yichen D Xu; Wei D Zhang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems